logo
HomeAboutProductsResearch News & EventsEducation & Training PublicationsContactserch
 

New collaboration to develop periodontitis vaccine

 

The CRC for Oral Health Science has entered an agreement with CSL Limited and Sanofi Pasteur to develop a vaccine against periodontitis.

 
View More...

Australia's oral health set to improve with $31.6m funding boost

 

The new CRC will further the work of the existing CRC for Oral Health Science on the discovery and development of new preventive products and treatments for oral diseases.

 
View More...
 

 

MEDIA RELEASE

  

Thursday 10 December 2009

 

CSL Ltd has signed an agreement with Sanofi Pasteur to fund a program in the CRC for Oral Health Science for the further development of a vaccine to prevent and treat the wide-spread gum disease periodontitis. 

 

Read the media release...

 

Watch an animation of how the new vaccine will work...

 

 

  More than 40,000 Australians a year are hospitalised for preventable dental conditions.

  Almost half of Australia’s 6 year-olds have cavities in their baby teeth. 25% of Australian adults have untreated dental decay.

  20% of Australian adults have moderate or severe cases of the gum disease periodontitis.

  The current cost of dental treatment in Australia is $5.7 billion a year.

  There is growing evidence that dental disease is linked to systemic diseases such as cancer, cardiovascular disease and diabetes.

 

 

 Recent video and podcasts:

 

 

 

 

 

 

The Cooperative Research Centre for Oral Health Science brings together scientists, dentists, population health experts and manufacturers to find new and efficient ways of reducing the burden of oral disease in Australia.

+
Read more about us

New periodontitis treatment 16-Dec   
What is periodontitis? 16-Dec   
How the vaccine works 16-Dec   
News Feeds 16-Dec   
Home 16-Dec